Potential 100 bagger Biotech missed by the market, page-26

"has sold basically every stock except TEVA" – seriously, I don't know whether to report this for unsubstantiated or reply to it. I guess I'm feeling generous today.

This assertion is complete rubbish. Buffet's portfolio is worth around $US250 billion and TEVA isn't anywhere near his top holding!

And I think you're being a bit previous with your optimism about EmtinB... there are plenty of hurdles where it could fall over yet: it could fail the toxicity trial and it could fail the efficacy trials for each and every target condition. Given Buffet's investment outlook, it's highly unlikely that NSB would be of interest until the product is in the clear.